Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-02-03
1998-08-25
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514460, 514568, 514572, A61K 3144, A61K 3135, A61K 3119
Patent
active
057983720
ABSTRACT:
A method is provided for preventing or reducing the risk of restenosis following angioplasty by administering a retinoid, such as an RAR-selective retinoid, e.g. the compound of the formula: ##STR1##
REFERENCES:
patent: 4326055 (1982-04-01), Loeliger
patent: 4739098 (1988-04-01), Chandraratna
patent: 5116864 (1992-05-01), March et al.
patent: 5140012 (1992-08-01), McGovern et al.
patent: 5166143 (1992-11-01), Ondetti et al.
patent: 5213561 (1993-05-01), Weinstein et al.
patent: 5324840 (1994-06-01), Chandraratna
patent: 5326898 (1994-07-01), Chandraatra
CA 109:55005, Chandraratna, Apr. 1988.
CA 116:227585, Chien et al, 1992.
CA 117:97170, McCarthy et al, 1991.
Serruys et al; Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon; Therapy and Prevention-Coronary Angioplasty; vol. 77, No. 2, pp. 361-371, Feb. 1988.
Willerson et al; Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neoointimal proliferation following experimental coronary stenosis and endothelial injury; Proc. Natl. Acad. Sci.; vol. 88, pp. 10624-10628, Dec. 1991; Medical Sciences.
Pakala et al, "All Trans-retinoic acid and its derivatives inhibit serotonin-induced vascular smooth cell proliferation", Journal of the American College of Cardiology, vol. 0 (spec. issue), 1995, pp. 83A-84A, Abstract No. 713-2.
Lyons et al, "Effect of oral 13-cis-retinoic acid on serum lipids", British Journal of Dermatology, vol. 107, 1982, pp. 591-595.
Kato et al, "Down-regulation in the production of matrix metalloproteinase 1 by human aortic intimal smooth muscle cells", Biochem. Mol. Biol. Int., vol. 31, No. 2, Oct. 1993, pp. 239-248.
Hayashi et al, "Modulations of elastin expression and cell proliferation by retinoids in cultured vascular smooth muscle cells", J. Biochem., vol. 117, No. 1, 1995, pp. 132-136.
Liu et al, "Systemic pharmacokinetics of acetylenic retinoids in rats", Drug Metab. Dispos., vol. 18, No. 6, 1990, pp. 1071-1077.
Barstad et al, "Retinoic acid reduces induction of monocyte tissue factor and tissue factor/factor VIIa-dependent arterial thrombus formation", Blood, vol. 86, No. 1, 1 Jul. 1995, pp. 212-218.
Chemical Abstracts, vol. 111, No. 3, 17 Jul. 1989, Abstract No. 23742, see Abstract & J. Med. Chem. vol. 32, No. 5, 1989 Kagechika et al, "Retinobenzoic acids".
Benedict Claude R.
Chandraratna Roshantha A.
Davies Peter A. J.
Allergan
Baran Robert J.
Jordan Kimberly
Lambert Howard R.
The University of Texas
LandOfFree
Method for preventing onset of restenosis after angioplasty empl does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for preventing onset of restenosis after angioplasty empl, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for preventing onset of restenosis after angioplasty empl will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-36617